Celestica Inc
TSX:CLS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
94.08
497.19
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
CLS
stock under the Base Case scenario is
272.81
CAD.
Compared to the current market price of 407.37 CAD,
Celestica Inc
is
Overvalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Celestica Inc.
| CN |
|
Foxconn Industrial Internet Co Ltd
SSE:601138
|
|
| TW |
|
Hon Hai Precision Industry Co Ltd
TWSE:2317
|
|
| CH |
|
TE Connectivity Ltd
NYSE:TEL
|
|
| SG |
|
Flex Ltd
NASDAQ:FLEX
|
|
| US |
|
Jabil Inc
NYSE:JBL
|
|
| KY |
|
Fabrinet
NYSE:FN
|
|
| CN |
|
Goertek Inc
SZSE:002241
|
|
| TW |
|
FIH Mobile Ltd
F:FW3
|
|
| US |
F
|
Fabrinet
SWB:FAN
|
|
| US |
|
Sanmina Corp
NASDAQ:SANM
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Celestica’s reliance on cyclical end markets, particularly aerospace and industrial, could amplify revenue volatility in an economic slowdown, exposing the company to sharper demand swings than more diversified peers.
Continued pricing pressure from major OEM customers may squeeze margins for Celestica’s core manufacturing services, given the company’s narrower scale relative to larger EMS competitors with deeper cost structures.
If Celestica fails to effectively integrate acquisitions and optimize its global manufacturing footprint, it risks heightened operational complexity and potential cost overruns, undermining long-term profitability.
Celestica’s focus on diversified, high-value segments like aerospace, defense, and healthcare can drive steadier revenue streams and higher margins as these markets grow and require more technically complex services.
Strategic investments in design, engineering, and supply chain capabilities position Celestica for long-term partnerships with customers seeking end-to-end manufacturing solutions, potentially resulting in stronger pricing power.
Successful execution of cost-saving initiatives—such as consolidating manufacturing sites and enhancing automation—could expand Celestica’s margins and boost competitiveness against larger EMS providers.
Revenue & Expenses Breakdown
Celestica Inc
Balance Sheet Decomposition
Celestica Inc
| Current Assets | 5.1B |
| Cash & Short-Term Investments | 305.9m |
| Receivables | 2.4B |
| Other Current Assets | 2.4B |
| Non-Current Assets | 1.5B |
| PP&E | 676.4m |
| Intangibles | 616.1m |
| Other Non-Current Assets | 171.4m |
| Current Liabilities | 3.5B |
| Accounts Payable | 1.7B |
| Accrued Liabilities | 1.3B |
| Other Current Liabilities | 530.9m |
| Non-Current Liabilities | 1.1B |
| Long-Term Debt | 756.7m |
| Other Non-Current Liabilities | 319.1m |
Free Cash Flow Analysis
Celestica Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Celestica Inc
|
Revenue
|
11.3B
USD
|
|
Cost of Revenue
|
-9.9B
USD
|
|
Gross Profit
|
1.4B
USD
|
|
Operating Expenses
|
-531.8m
USD
|
|
Operating Income
|
826.4m
USD
|
|
Other Expenses
|
-109.7m
USD
|
|
Net Income
|
716.7m
USD
|
CLS Profitability Score
Profitability Due Diligence
Celestica Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Celestica Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
CLS Solvency Score
Solvency Due Diligence
Celestica Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Score
Celestica Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CLS Price Targets Summary
Celestica Inc
According to Wall Street analysts, the average 1-year price target for
CLS
is 347.67 CAD
with a low forecast of 177.76 CAD and a high forecast of 420 CAD.
Dividends
Current shareholder yield for
CLS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CLS
stock under the Base Case scenario is
272.81
CAD.
Compared to the current market price of 407.37 CAD,
Celestica Inc
is
Overvalued by 33%.